What Researchers Did
Researchers investigated how elevated oxygen partial pressures affect carboxyhemoglobin elimination in 12 healthy adult volunteers using a double crossover prospective analysis in an inflatable hyperbaric chamber.
What They Found
They found a significant increase in the half-life of carboxyhemoglobin (COHb) when subjects breathed normobaric oxygen (NBO2) compared to hyperbaric oxygen (HBO2). The average COHb half-life was 26.3 ± 3.7 minutes with HBO2, significantly shorter than the 71.3 ± 9.9 minutes observed with NBO2. A significant shift from zero to first-order COHb elimination kinetics was also observed with elevated oxygen partial pressure (P = 0.002).
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy is more effective than normobaric oxygen in accelerating the elimination of carboxyhemoglobin in patients with low-level carbon monoxide poisoning. Canadian patients experiencing carbon monoxide exposure may benefit from prompt access to hyperbaric oxygen treatment to reduce COHb levels more quickly.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
A limitation of this study is its small sample size of 12 healthy volunteers, which may not fully represent the diverse patient population experiencing carbon monoxide poisoning.